SADC Pharmaceutical Industry

Frost & Sullivan, November 2010, Pages: 114

This study covers the pharmaceutical industry in key SADC countries, including Malawi, Mauritius and Zambia. The research service provides detailed metrics on the pharmaceutical industries, encompassing the OTC and prescription markets, as well as the branded and generic markets. The research examines drivers and restraints for growth, distribution, and geographical trends. Following from these, market growth are forecasted. In addition, an in-depth analysis of the competitive situation including vendors’ competitive rankings is provided. The base year is 2009 with forecasts running through 2016. The market is further divided into four subsegments including oncology, anti-diabetic drugs, anti-infective drugs and cardiovascular drugs.

This research service titled SADC Pharmaceutical Industry provides an analysis of four therapeutic segments in Mauritius, Zambia and Malawi. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: anti-infective, oncology, diabetes and cardiovascular.

Market Overview

Improved Access to Pharmaceuticals Critical to Tackling the Increase in Infectious and Non-communicable Diseases

Infectious diseases in the Southern African Development Community (SADC) countries still present the biggest burden of disease. However, urbanisation and westernised lifestyles have led to the rise of non-communicable diseases, especially in countries like Mauritius, where they account for a majority of the country’s disease burden. Increased access to high-quality treatments is essential in alleviating the heavy burden of non-communicable diseases within the country. “The rapidly increasing number of diseases in SADC is the biggest driver of growth in the region,” notes the analyst of this research. “Infectious diseases, including AIDS, malaria and TB still present the largest opportunity for the provision of pharmaceuticals in the region, especially in Zambia and Malawi.” The high burden of infectious diseases will spur strong investments in anti-infective treatments. At the same time, the large number of non-communicable or lifestyle diseases like hypertension and diabetes will also drive market development.

“Rapid industrialisation and the consequent change to a more westernised lifestyle has contributed to the high prevalence of non-communicable disease risk factors in Mauritius,” remarks the analyst. “These include obesity (10.3%), abusive alcohol consumption (19.1%) and tobacco consumption (35.9% among males).” Non-communicable diseases such as cardiovascular disease and diabetes are the most common diseases in both hospital and non-hospital settings. They account for over 80.0 per cent of Mauritius’s disease burden. Mauritius ranks among the countries with the highest prevalence of diabetes mellitus and hypertension in Africa.

Limited buying power, an acute shortage of skilled healthcare workers and poor distribution infrastructure to rural areas still limit the access to essential treatments. Furthermore, the proliferation of low-quality and counterfeit products remains a major challenge for reputable pharmaceutical suppliers, as these products pose direct competition to high-quality pharmaceuticals. “Increased access to high quality treatments is essential in alleviating the high burden of non-communicable diseases,” advises the analyst. “Recently, the Ministry of Health in Mauritius has devoted more attention to the threat of non-communicable disease, realising that the high disease burden not only impacts healthcare services but also has a profound social and economic impact on the country.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

- Anti-infectives
- Oncology
- Diabetes
- Cardiovascular

By Country:

- Zambia
- Malawi
- Mauritius

1. Executive Summary

2. Research Aim and Objectives

3. Research Scope and Definitions

4. Research Methodology

5. Pharmaceutical Industry in SADC
5.1 Introduction
5.2 Industry Challenges, Drivers and Restraints
5.3 Pharmaceutical Industry Revenue Forecasts
5.4 Segmental Revenue Forecasts
5.5 Revenue Forecasts by Therapeutic Segment
5.6 Strengths, Weaknesses, Opportunities, Threats Analysis

6. Mauritius Pharmaceutical Industry
6.1 Country Overview
6.2 Healthcare Overview
6.3 Pharmaceutical Industry Overview
6.4 Market Engineering Measurements
6.5 Pharmaceutical Industry Revenue Forecasts
6.6 Growth of Key Segments
6.7 Revenue Forecasts by Therapeutic Segment
6.8 Competitive Structure
6.9 Local Manufacturing
6.10 Competitor Analysis
6.11 Opportunity Analysis

7. Malawi Pharmaceutical Industry
7.1 Country Overview
7.2 Healthcare Overview
7.3 Pharmaceutical Industry Overview
7.4 Market Engineering Measurements
7.5 Pharmaceutical Industry Revenue Forecasts
7.6 Growth of Key Segments
7.7 Revenue Forecasts by Therapeutic Segment
7.8 Competitive Structure
7.9 Local Manufacturing
7.10 Competitor Analysis
7.11 Opportunity Analysis

8. Zambia Pharmaceutical Industry
8.1 Country Overview
8.2 Healthcare Overview
8.3 Pharmaceutical Industry Overview
8.4 Market Engineering Measurements
8.5 Pharmaceutical Industry Revenue Forecasts
8.6 Growth of Key Segments
8.7 Revenue Forecasts by Therapeutic Segment
8.8 Competitive Structure
8.9 Local Manufacturing
8.10 Competitor Analysis
8.11 Opportunity Analysis

9. Conclusions

10. About Frost & Sullivan

List of Figures

Pharmaceutical Industry: Challenges, Drivers and Restraints (SADC Countries), 2010-2016
Pharmaceutical Industry: Industry Challenges, Market Drivers and Market Restraints (SADC Countries), 2010-2016
Pharmaceutical Industry: Demographic Indicators (Mauritius), 2009
Pharmaceutical Industry: Number of Public Healthcare Facilities (Mauritius), 2009
Pharmaceutical Industry: Healthcare Financing (Mauritius), 2009
Pharmaceutical Industry: Revenue Forecasts (Mauritius), 2009-2016
Pharmaceutical Industry: Competitive Structure (Mauritius), 2009
Pharmaceutical Industry: Key Local Manufacturers (Mauritius), 2009
Pharmaceutical Industry: Key Ethical Suppliers by Rank (Mauritius), 2009
Pharmaceutical Industry: Key Generic Suppliers by Rank (Mauritius), 2009
Pharmaceutical Industry: Number of Public Healthcare Facilities (Malawi), 2009
Pharmaceutical Industry: Healthcare Financing (Malawi), 2009
Pharmaceutical Industry: Revenue Forecasts (Malawi), 2009-2016
Pharmaceutical Industry: Competitive Structure (Malawi), 2009
Pharmaceutical Industry: Key Pharmaceutical Suppliers by Rank (Malawi), 2009
Pharmaceutical Industry: Key Pharmaceutical Distributors by Rank (Malawi), 2009
Pharmaceutical Industry: Demographic Indicators (Zambia), 2009
Pharmaceutical Industry: Number of Healthcare Facilities (Zambia), 2009
Pharmaceutical Industry: Number of Healthcare Workers (Zambia), 2006-2008
Pharmaceutical Industry: Revenue Forecasts (Zambia), 2009-2016
Pharmaceutical Industry: Competitive Structure (Zambia), 2009
Pharmaceutical Industry: Key Local Manufacturers (Zambia), 2009
Pharmaceutical Industry: Key Ethical Suppliers by Rank (Zambia), 2009
Pharmaceutical Industry: Key Generic Suppliers by Rank (Zambia), 2009
Pharmaceutical Industry: Key Pharmaceutical Distributors (Zambia), 2009
Pharmaceutical Industry: Market Size and Anticipated Growth in Therapeutic Segment (SADC Countries), 2009

List Of Charts:

Pharmaceutical Industry: Market Segmentation (SADC Countries), 2009
Pharmaceutical Industry: Per Cent of Revenues by Geographic Region (SADC Countries), 2009
Pharmaceutical Industry: Per Cent of Revenues by Product Segment (SADC Countries), 2009
Pharmaceutical Industry: Per Cent of Revenues by Geographic Region (SADC Countries), 2009
Pharmaceutical Industry: Revenue Forecasts by Country (SADC Countries), 2009-2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (SADC Countries), 2009
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (SADC Countries), 2016
Pharmaceutical Industry: Growth Potential (SADC Countries), 2009-2016
Pharmaceutical Industry: Per Cent of Revenues by Geographic Region (SADC Countries), 2009 and 2016
Pharmaceutical Industry: Revenue Forecasts by Product Segment (SADC Countries), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Product Segment (SADC Countries), 2009 and 2016
Pharmaceutical Industry: Revenue Forecasts by Therapeutic Segment (SADC Countries), 2009 and 2016
Pharmaceutical Industry: Number of Healthcare Workers (Mauritius), 2006-2008
Pharmaceutical Industry: Revenue Contribution to Healthcare Financing (Mauritius), 2009
Pharmaceutical Industry: Market Size by Segmentation (Mauritius), 2009
Pharmaceutical Industry: Market Engineering Measurements (Mauritius), 2009
Pharmaceutical Industry: Revenue Forecasts (Mauritius), 2009-2016
Pharmaceutical Industry: Revenue Forecasts by Product Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Revenue Forecasts by Product Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Mauritius), 2009 and 2016
Pharmaceutical Industry: Opportunities in Therapeutic Segments (Mauritius), 2009
Pharmaceutical Industry: Public and Private Revenue Contribution to Healthcare Financing (Malawi), 2006
Pharmaceutical Industry: Market Size by Segmentation (Malawi), 2009
Pharmaceutical Industry: Market Engineering Measurements (Malawi), 2009
Pharmaceutical Industry: Revenue Forecasts (Malawi), 2009-2016
Pharmaceutical Industry: Revenue Growth of Key Segments (Malawi), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Segment (Malawi), 2009 and 2016
Pharmaceutical Industry: Revenue Growth of Therapeutic Segments (Malawi), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Malawi), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Malawi), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Malawi), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Malawi), 2009 and 2016
Pharmaceutical Industry: Opportunities in Therapeutic Segments (Malawi), 2009
Pharmaceutical Industry: Health Facility Ownership (Zambia), 2009
Pharmaceutical Industry: Sources of Funding (Zambia), 2009
Pharmaceutical Industry: Market Size by Segmentation (Zambia), 2009
Pharmaceutical Industry: Market Engineering Measurements (Zambia), 2009
Pharmaceutical Industry: Revenue Forecasts (Zambia), 2009-2016
Pharmaceutical Industry: Revenue Growth of Key Segments (Zambia), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Segments (Zambia), 2009 and 2016
Pharmaceutical Industry: Revenue Growth of Therapeutic Segments (Zambia), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Zambia), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Zambia), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Zambia), 2009 and 2016
Pharmaceutical Industry: Per Cent of Revenues by Therapeutic Segment (Zambia), 2009 and 2016
Pharmaceutical Industry: Opportunities in Therapeutic Segments (Zambia), 2009
Pharmaceutical Industry: Attractiveness of Therapeutic Segments by Country (SADC Countries), 2009
Pharmaceutical Industry: Attractiveness of Therapeutic Segments by Country (SADC Countries), 2009

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Healthcare Overview in Zimbabwe
• Healthcare Overview of Mozambique
• Clinical Diagnostics Industry in East Africa
• Overview of the Healthcare Industry in Angola
• The Middle East & Africa Pharmaceutical & Healthcare Reports
• The Clinical Laboratory Instrumentation Market in Key West African Countries
• Healthcare Industry Overview in Ethiopia
• Strategic Analysis of the Healthcare Industry in Zambia
• Southern Africa Pharmaceuticals and Healthcare Report Q3 2012
• Distributor Analysis in Nigeria